Lupin Pharmaceuticals Inc. recalls Lupin Cefdinir powder for Oral Suspension USP, 250 mg/5 mL in (a) 60 mL packs ( NDC 68180-723-20) and (b) 100 mL packs
Recalled April 25, 2018 · FDA recall D-0684-2018 · Lupin Pharmaceuticals
Hazard
Superpotent Drug · FDA Class II
Units
40,824 bottles
Sold at
Nationwide
Description
Superpotent Drug
Product
Lupin Cefdinir powder for Oral Suspension USP, 250 mg/5 mL in (a) 60 mL packs ( NDC 68180-723-20) and (b) 100 mL packs ( 68180-723-10), Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202
Manufacturer(s)
Lupin Pharmaceuticals Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →